You are currently viewing Artificial Intelligence In Drug Repurposing Market Segmentation And Growth Analysis: Insights Through 2030
Artificial Intelligence In Drug Repurposing Market Analysis

Designed to make market research more actionable and strategically valuable, The Business Research Company’s 2026 market reports feature market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.

Artificial Intelligence In Drug Repurposing Market Forecast 2026–2030: Size, Value And Compound Annual Growth Rate

The artificial intelligence in drug repurposing market has experienced significant growth in recent years. This market is set to expand from $1.05 billion in 2025 to $1.27 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.3%. This historical expansion can be attributed to several factors, including escalating research and development costs within pharmaceutical development, the increasing availability of public biomedical datasets, advancements in computational biology tools, the imperative to accelerate the market entry of new therapies, and a rise in collaborations between pharmaceutical companies and AI startups.

The artificial intelligence in drug repurposing market size is anticipated to undergo significant expansion in the foreseeable future. This market is projected to reach $2.63 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 20.1%. This anticipated growth during the forecast period stems from factors such as the increasing prevalence of AI-assisted clinical decision support, the rising application of generative AI for insights into molecules, the critical need for accelerated repurposing during health crises, the broadening scope of real-world evidence analytics, and amplified investments in precision medicine pipelines. Notable trends expected in this period include AI-driven drug-target matching derived from multi-omics data, the establishment of repurposing pipelines utilizing knowledge graph discovery, the acceleration of virtual screening and trial simulations, the integration of federated learning for cross-institution research, and the deployment of explainable AI to inform clinical repurposing decisions.

Try Before You Buy: Free Sample Of The Artificial Intelligence In Drug Repurposing Market Report:

https://thebusinessresearchcompany.com/sample_request?id=51368347&type=smp&name=Artificial%20Intelligence%20In%20Drug%20Repurposing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Artificial Intelligence In Drug Repurposing Market Growth Engine: The Factor Boosting Demand Globally

The increasing need for precision medicine is anticipated to drive the expansion of the artificial intelligence in drug repurposing market in the future. Precision medicine represents a healthcare strategy that tailors disease prevention and therapy according to an individual’s unique genetic makeup, lifestyle, and surroundings. The growing requirement for individualized treatments is fueling the advancement of precision medicine, given that patients and medical professionals are increasingly looking for therapies customized to personal genetic and lifestyle characteristics for enhanced efficacy and fewer adverse reactions. Artificial intelligence-powered drug repurposing improves precision medicine by identifying existing medications that correspond with a person’s genetic or molecular attributes, thereby facilitating more precise and individualized therapeutic options. For example, in February 2024, data from the Personalized Medicine Coalition, a US-based nonprofit group, indicated that the FDA approved 16 personalized treatments for rare conditions in 2023, showing a significant increase from the six approvals given in 2022. Consequently, the expanding need for precision medicine is accelerating the growth of the artificial intelligence in drug repurposing market.

Which Categories And Subcategories Shape The Artificial Intelligence In Drug Repurposing Market?

The artificial intelligence in drug repurposing market covered in this report is segmented –

1) By Component: Software And Platforms, Services

2) By Technology: Machine Learning Or Deep Learning, Natural Language Processing (NLP), Knowledge Graphs And Network-Based Artificial Intelligence, Generative Artificial Intelligence And Large Language Models (LLMs), Computer Vision

3) By Deployment: Cloud-Based, On-Premises

4) By Therapeutic Area: Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases

5) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Healthcare Providers, Other End-Users

Subsegments:

1) By Software And Platforms: Predictive Analytics Tools, Machine Learning Frameworks, Data Integration Systems, Drug Discovery Platforms, Clinical Trial Simulation Tools

2) By Services: Consulting Services, Data Management Services, Model Training And Optimization Services, Implementation And Integration Services, Support And Maintenance Services

Artificial Intelligence In Drug Repurposing Market Trend Insights: Strategic Focus Areas Of Leading Companies

Leading companies operating in the artificial intelligence in drug repurposing market are concentrating on integrating advanced technologies into drug repositioning efforts, such as computational drug repositioning systems. These systems systematically identify new therapeutic applications for existing medications by employing data-driven analysis of literature and biological information. A computational drug repositioning system represents a technology-driven platform that utilizes artificial intelligence, machine learning, and data mining to systematically analyze existing drugs, compounds, and biological data. For instance, in November 2023, Tempus, a US-based provider of AI-based precision medicine solutions, announced a multi-year strategic collaboration with Recursion, a US-based clinical stage biotechnology company, with a valuation of up to $160 million over five years. This partnership grants Recursion access to Tempus’ extensive library of de-identified, multimodal oncology data to support biomarker-driven therapeutic development. By leveraging Tempus’ large-scale patient datasets alongside Recursion’s AI-enabled discovery capabilities, the collaboration strengthens oncology drug repurposing initiatives, illustrating how advanced computational platforms combined with real-world clinical data can accelerate the discovery of new treatment opportunities.

Leading Organizations In The Artificial Intelligence In Drug Repurposing Market

Major companies operating in the artificial intelligence in drug repurposing market are IBM Corporation, Evogene Ltd., Ginkgo Bioworks Holdings Inc., BioAge Labs Inc., Insilico Medicine Inc., BostonGene Corporation, ISOMORPHIC LABS, Recursion Pharmaceuticals Inc., Deep Genomics Inc., Healx Ltd., Owkin Inc., BullFrog AI Holdings Inc., Aicura Medical GmbH, Kantify, Ignota Labs Ltd., OrphAI Therapeutics, Nabla Bio, Atomwise Inc., BioXcel Therapeutics Inc., Graph AI.

Continue Reading: The Full Artificial Intelligence In Drug Repurposing Market Report:

https://thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-repurposing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Artificial Intelligence In Drug Repurposing Market Regional Spotlight: Top Geography And Report Coverage

North America was the largest region in the artificial intelligence in drug repurposing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in drug repurposing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model